Patents-Review.com
ClassID:

20081 ⎘

A61K9/1611 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients Inorganic compounds

Recent Application in this class:
#301
20210392880
2021-12-23

STABLE MICROBIAL COMPOSITION AND DRYING PROCESS

 #302
20210369618
2021-12-02

IBUPROFEN-CONTAINING ORAL PHARMACEUTICAL FORMULATION

 #303
20210369617
2021-12-02

Lyophilized mesenchymal stem cell derived secretome and uses thereof

 #304
20210369614
2021-12-02

Physiologically active substance carrier

 #305
20210361748
2021-11-25

Pharmaceutical or food supplement preparation based on alpha-lactalbumin

 #306
20210361580
2021-11-25

Storage stable sincalide formulations

 #307
20210353758
2021-11-18

MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR

 #308
20210353719
2021-11-18

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

 #309
20210353544
2021-11-18

METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES

 #310
20210309665
2021-10-07

Compound having TrkA inhibitory activity and pharmaceutical composition, for preventing or alleviating pain, containing same as active ingredient

 #311
20210308057
2021-10-07

PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS

 #312
20210308056
2021-10-07

Pharmaceutical composition

 #313
20210290554
2021-09-23

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

 #314
20210290542
2021-09-23

COMPOSITIONS AND METHODS OF USE

 #315
20210290541
2021-09-23

SOLID DISPERSION OF HYDANTOIN DERIVATIVE

 #316
20210283237
2021-09-16

VACCINE COMPOSITIONS

 #317
20210283130
2021-09-16

Gastro-resistant formulation containing posaconazole

 #318
20210283115
2021-09-16

Formulations of hydroxypyridonate actinide/lanthanide decorporation agents

 #319
20210267898
2021-09-02

Pharmaceutical Formulation with Improved Solubility and Bioavailability

 #320
20210259991
2021-08-26

Methods and Compositions for Delivering Retinaldehyde to a Topical Location of a Subject

 #321
20210251903
2021-08-19

Preparation of Microparticulate Triamcinolone Acetonide Injectable Suspension

 #322
20210251901
2021-08-19

Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same

 #323
20210244669
2021-08-12

FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY

 #324
20210244667
2021-08-12

HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS

 #325
20210236629
2021-08-05

SELF-EMULSIFYING DOSAGE FORMS OF ALLERGEN AND THEIR PREPARATION THEREOF

 #326
20210236459
2021-08-05

Composition for buccal or sublingual administration of cannabis extract and methods for making same

 #327
20210230602
2021-07-29

Composition for inhibiting CTGF expression

 #328
20210228722
2021-07-29

QUINOLINE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION

 #329
20210228572
2021-07-29

Device And Kit For Dosing And Dispensing Non-Liquid Medicine

 #330
20210228550
2021-07-29

Inhibiting germination of Clostridium perfringens spores to reduce necrotic enteritis

 #331
20210228505
2021-07-29

Method of treating major depressive disorder

 #332
20210220334
2021-07-22

Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof

 #333
20210220278
2021-07-22

Immediate release formulations of cannabinoids

 #334
20210220277
2021-07-22

Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto

 #335
20210220276
2021-07-22

Methods of Treating Skin

 #336
20210220260
2021-07-22

TOPICAL INJECTABLE COMPOSITION

 #337
20210214343
2021-07-15

Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof

 #338
20210212991
2021-07-15

Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof

 #339
20210196683
2021-07-01

Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof

 #340
20210196682
2021-07-01

Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof

 #341
20210196636
2021-07-01

Process for producing a pharmaceutical composition containing micro particles

 #342
20210196635
2021-07-01

DRUG-CONTAINING PARTICLE

 #343
20210187110
2021-06-24

Surfactants for use in healthcare products

 #344
20210186885
2021-06-24

POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS

 #345
20210186879
2021-06-24

TARGETED DELIVERY OF HYDROPHILIC DRUGS TO LUNG

 #346
20210186861
2021-06-24

COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS

 #347
20210177842
2021-06-17

PIMOBENDAN FORMULATION AND METHOD OF USE THEREOF

 #348
20210177762
2021-06-17

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

 #349
20210161996
2021-06-03

Granular Pharmaceutical Composition

 #350
20210161849
2021-06-03

STORAGE STABLE MIXTURES, METHOD OF IMPROVING RETENTION OF A COMPOUND AND USE OF RICE HULLS AND/OR RICE BRAN TO ENHANCE RETENTION OF A COMPOUND

 #351
20210161846
2021-06-03

A STABLE PHARMACEUTICAL COMPOSITION COMPRISING PENICILLAMINE

 #352
20210161820
2021-06-03

GRANULATION COMPOSITION

 #353
20210154146
2021-05-27

COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION

 #354
20210153540
2021-05-27

Dust-free cold-water-dispersible preparations

 #355
20210145941
2021-05-20

PHARMACEUTICAL COMPOSITIONS FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY

 #356
20210145901
2021-05-20

Freeze-dried formulations including nanoparticles and methods of freeze-drying

 #357
20210145866
2021-05-20

Materials and methods relating to stabilised polymeric silicate compositions

 #358
20210145756
2021-05-20

PHARMACEUTICAL COMPOSITIONS

 #359
20210137970
2021-05-13

NITRIC OXIDE-RELEASING PARTICLES

 #360
20210137921
2021-05-13

STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN

 #361
20210137855
2021-05-13

Benzalkonium-embedded mesostructured silica compositions and uses of same

 #362
20210128583
2021-05-06

INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES

 #363
20210113542
2021-04-22

Methods and compositions for self-regulated release of active pharmaceutical ingredients

 #364
20210113481
2021-04-22

ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION

 #365
20210106589
2021-04-15

Solid dosage form having excellent stability

 #366
20210093554
2021-04-01

Method for making injectable pharmaceutical compositions

 #367
20210077474
2021-03-18

Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

 #368
20210077401
2021-03-18

Non-surfactant type oil-water dispersion composition, non-surfactant type water-oil dispersion composition, and manufacturing methods for both compositions

 #369
20210069114
2021-03-11

Method for preparing granules

 #370
20210069105
2021-03-11

Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release

 #371
20210060268
2021-03-04

Inhalable dry powders

 #372
20210060090
2021-03-04

Compositions comprising bacterial species and methods related thereto

 #373
20210059945
2021-03-04

Oral Drug Delivery System and Method for Fabricating Thereof

 #374
20210052500
2021-02-25

MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS

 #375
20210038520
2021-02-11

MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS

 #376
20210023067
2021-01-28

PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF

 #377
20210015739
2021-01-21

Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same

 #378
20210008090
2021-01-14

PARTICULATE SUBSTANCE MIXTURE, PREFERABLY FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A RESPIRATORY DISORDER

 #379
20210008008
2021-01-14

Methods of preparing compositions containing thymoquinone

 #380
20210000741
2021-01-07

Pharmaceutical compositions comprising silica microspheres

 #381
20200390709
2020-12-17

PROCEDURE FOR PREPARING ENTERIC-COATED PELLETS CONTAINING A PROTON PUMP INHIBITOR AND MULTI-PARTICLE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

 #382
20200390708
2020-12-17

Multilayer beads for pharmaceutical use

 #383
20200383920
2020-12-10

Method for producing sweetener compositions and sweetener compositions

 #384
20200368166
2020-11-26

Oral Formulations And Uses Thereof

 #385
20200360288
2020-11-19

Method and devices for delivering therapeutics by oral, respiratory, mucosal, transdermal routes

 #386
20200338069
2020-10-29

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #387
20200338008
2020-10-29

Coated Drug Compositions and Methods of Preparing the Same

 #388
20200323894
2020-10-15

Combination formulation of three antiviral compounds

 #389
20200323779
2020-10-15

Gelling multiparticulates

 #390
20200297732
2020-09-24

PHARMACEUTICAL FORMULATION

 #391
20200297664
2020-09-24

Process for Manufacturing Stable Epinephrine

 #392
20200297637
2020-09-24

Carotenoid-containing particles

 #393
20200289546
2020-09-17

Compounds to modulate intestinal absorption of nutrients

 #394
20200289478
2020-09-17

Solid dispersions comprising tacrolimus

 #395
20200289419
2020-09-17

Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activation

 #396
20200276188
2020-09-03

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #397
20200276160
2020-09-03

Triptan Powders for Pulmonary Delivery

 #398
20200276126
2020-09-03

POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS

 #399
20200276111
2020-09-03

Sterile lyophilized drug compositions and methods for treating ocular diseases or conditions

 #400
20200268748
2020-08-27

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #401
20200268669
2020-08-27

Compositions and methods for the treatment and prophylaxis of surgical site infections

 #402
20200261667
2020-08-20

Inhalable dry powders

 #403
20200254046
2020-08-13

PHARMACEUTICAL COMPOSITIONS

 #404
20200246366
2020-08-06

Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases

 #405
20200246278
2020-08-06

INJECTABLE DIETHYLSTILBESTROL NANOSUSPENSION FORMULATION

 #406
20200222336
2020-07-16

Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same

 #407
20200206305
2020-07-02

Granular Pharmaceutical Composition

 #408
20200188303
2020-06-18

ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHODS FOR THE PRODUCTION THEREOF

 #409
20200171154
2020-06-04

Production of nanoscale powders of embedded nanoparticles

 #410
20200164087
2020-05-28

MINERAL COATED MICROPARTICLES FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES

 #411
20200164048
2020-05-28

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

 #412
20200163887
2020-05-28

Process for preparation of an enteric coated granulate comprising dimethyl fumarate

 #413
20200163885
2020-05-28

COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL

 #414
20200163882
2020-05-28

Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists

 #415
20200155620
2020-05-21

Probiotic formulations and methods for use

 #416
20200147074
2020-05-14

Manufacturing process of formulation having improved content uniformity

 #417
20200147005
2020-05-14

Method of treating major depressive disorder

 #418
20200138858
2020-05-07

SILVER OXIDE FORMULATIONS

 #419
20200138857
2020-05-07

Vanadium insulin-mimetics, methods of preparation, and methods for treatment of diabetes

 #420
20200138718
2020-05-07

Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same

 #421
20200121603
2020-04-23

Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same

 #422
20200113835
2020-04-16

Injectable long-acting naltrexone microparticle compositions

 #423
20200101151
2020-04-02

Vaccine compositions having improved stability and immunogenicity

 #424
20200101018
2020-04-02

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

 #425
20200093747
2020-03-26

Formulations and methods for lyophilization and lyophilates provided thereby

 #426
20200085941
2020-03-19

ANTIGENIC THERMOSTABLE POLIO VACCINES & RELATED METHODS

 #427
20200069715
2020-03-05

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

 #428
20200069631
2020-03-05

SOLID COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF

 #429
20200067554
2020-02-27

Preparation, method for producing preparation, and method for generating hydrogen

 #430
20200061108
2020-02-27

Pharmaceutical compositions comprising zinc

 #431
20200061022
2020-02-27

Immediate release formulations of cannabinoids

 #432
20200060973
2020-02-27

Pharmaceutical composition

 #433
20200060969
2020-02-27

Methods for treating lung disorders

 #434
20200054631
2020-02-20

Composition having improved flowabilty and methods for making and using the composition

 #435
20200046787
2020-02-13

EXTENDED RELEASE FORMULATIONS OF CANNABINOIDS

 #436
20200046649
2020-02-13

Storage-stable formulations

 #437
20200046642
2020-02-13

MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS

 #438
20200038476
2020-02-06

Low-Dose Stable Formulations of Linaclotide

 #439
20200030407
2020-01-30

Stable formulations of linaclotide

 #440
20200030317
2020-01-30

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #441
20200030232
2020-01-30

Starch-free soft chew for veterinary applications

 #442
20200024736
2020-01-23

Particle coating methods and apparatus

 #443
20200022917
2020-01-23

COMPOSITIONS AND METHODS OF MANUFACTURING PROTEIN MICROPARTICLES

 #444
20200022916
2020-01-23

Efficient aqueous encapsulation and controlled release of bioactive agents

 #445
20200009258
2020-01-09

Lactuloside compounds and preparation and use thereof

 #446
20200009216
2020-01-09

Stable Formulations of Linaclotide

 #447
20200009055
2020-01-09

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #448
20200009054
2020-01-09

Physiologically active substance carrier

 #449
20200000879
2020-01-02

Method of treatment

 #450
20200000803
2020-01-02

STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN

 #451
20190388384
2019-12-26

Composition for buccal or sublingual administration of cannabis extract and methods for making same

 #452
20190388350
2019-12-26

FORMULATION

 #453
20190375690
2019-12-12

Biochars for use with animals

 #454
20190365651
2019-12-05

Sustained release particle formulations

 #455
20190365641
2019-12-05

RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS OF USE

 #456
20190358163
2019-11-28

Heat-stable dry powder pharmaceutical compositions and methods

 #457
20190345038
2019-11-14

Method for producing calcium sulphate hemihydrate with unique properties

 #458
20190344235
2019-11-14

Method for producing biochar aggregate particles

 #459
20190344234
2019-11-14

Biochar Aggregate Particles

 #460
20190328711
2019-10-31

Medical treatment comprising enteral administration of edaravone

 #461
20190328668
2019-10-31

Method for the production of a dosage form

 #462
20190314277
2019-10-17

Methods for treating lung disorders

 #463
20190307695
2019-10-10

HEMP POWDER

 #464
20190307676
2019-10-10

Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems

 #465
20190290586
2019-09-26

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

 #466
20190274959
2019-09-12

Pharmaceutical composition and administrations thereof

 #467
20190262322
2019-08-29

Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile

 #468
20190247474
2019-08-15

Hemostatic compositions and methods of making thereof

 #469
20190240338
2019-08-08

Composition for treatment of infertility in a female subject

 #470
20190240244
2019-08-08

Compounds for cancer chemotherapeutic sensitization

 #471
20190240149
2019-08-08

Pharmaceutical compositions comprising silica microspheres

 #472
20190224233
2019-07-25

Materials and methods relating to stabilised polymeric silicate compositions

 #473
20190217118
2019-07-18

UPCONVERSION OF LIGHT FOR USE IN OPTOGENETIC METHODS

 #474
20190209644
2019-07-11

Stable formulations of linaclotide

 #475
20190209553
2019-07-11

Device and kit for dosing and dispensing non-liquid medicine

 #476
20190209531
2019-07-11

Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis

 #477
20190209495
2019-07-11

High-pH solid-state epinephrine formulation

 #478
20190201859
2019-07-04

Biochars, biochar extracts and biochar extracts having soluble signaling compounds and method for capturing material extracted from biochar

 #479
20190192439
2019-06-27

Microparticles for encapsulating probiotics, obtaining said microparticles and uses thereof

 #480
20190183896
2019-06-20

ONE STEP MILLING PROCESS FOR PREPARING MICRONIZED PALIPERIDONE ESTERS

 #481
20190183811
2019-06-20

COMPOSITION CONTAINING SQUALENE FOR IMPROVING MUSCLE FUNCTION AND PREVENTING MUSCLE DAMAGE

 #482
20190183801
2019-06-20

Method for the production of a dosage form

 #483
20190167612
2019-06-06

PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION WITH CONTROLLED DISSOLUTION RATE COMPRISING SUSTAINED-RELEASE PELLETS CONTAINING TAMSULOSIN HYDROCHLORIDE

 #484
20190167592
2019-06-06

PROCESS FOR DIRECTLY COMPRESSIBLE CO-PROCESSED EXCIPIENT FOR MODIFIED RELEASE APPLICATION

 #485
20190125824
2019-05-02

Powder formulation

 #486
20190125676
2019-05-02

COMPOSITIONS COMPRISING PROTON PUMP INHIBITORS FOR ORAL ADMINISTRATION

 #487
20190125675
2019-05-02

Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto

 #488
20190117734
2019-04-25

System and Method for Multiphasic Release of Growth Factors

 #489
20190117558
2019-04-25

Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same

 #490
20190111050
2019-04-18

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #491
20190105273
2019-04-11

Active ingredient containing stabilised solid medicinal forms and methods for the production thereof

 #492
20190099372
2019-04-04

Formulations and methods for lyophilization and lyophilates provided thereby

 #493
20190083399
2019-03-21

DRUG DELIVERY COMPOSITION

 #494
20190076363
2019-03-14

Controlled release delivery device comprising an organosol coat

 #495
20190060395
2019-02-28

Granular Pharmaceutical Composition

 #496
20190060240
2019-02-28

Storage stable sincalide formulations

 #497
20190060237
2019-02-28

Powder for oral suspension containing lamotrigine

 #498
20190054081
2019-02-21

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #499
20190054025
2019-02-21

Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof

 #500
20190046522
2019-02-14

PHARMACEUTICAL FORMULATION CONTAINING IRRITANT

 #501
20190046468
2019-02-14

EXTENDED RELEASE LIQUID COMPOSITIONS OF GUAIFENESIN

 #502
20190038664
2019-02-07

Solid preparation, method for producing solid reparation, and method for generating hydrogen

 #503
20190038548
2019-02-07

Compositions for respiratory delivery of active agents and associated methods and systems

 #504
20190037967
2019-02-07

Article with at least one layered pod

 #505
20190029967
2019-01-31

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

 #506
20190029964
2019-01-31

Sumatriptan promethazine pharmaceutical compositions

 #507
20190029962
2019-01-31

Afatinib-containing formulation

 #508
20190029961
2019-01-31

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

 #509
20190022053
2019-01-24

Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)

 #510
20190022012
2019-01-24

METHOD FOR THE PRODUCTION OF A PHARMACEUTICAL DELIVERY SYSTEM

 #511
20190022007
2019-01-24

Hierarchical siliceous mesosilicalite nanocarrier

 #512
20190015357
2019-01-17

Premixture and pharmaceutical composition for the oral administration of memantine as a permanent suspension or one prepared prior to administering to the patient and optionally by enteral feeding tube and corresponding procedures

 #513
20190015337
2019-01-17

Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient

 #514
20190015313
2019-01-17

Mucin coated silica for bacterial aggregation

 #515
20190008965
2019-01-10

Multifunctional Metal Nanoparticles Having a Polydopamine-Based Surface and Methods of Making and Using the Same

 #516
20180369237
2018-12-27

Tamper-resistant dosage form with immediate release and resistance against solvent extraction

 #517
20180360748
2018-12-20

Methods for treating lung disorders

 #518
20180353605
2018-12-13

Ferritin nanoparticle compositions and methods to modulate cell activity

 #519
20180344821
2018-12-06

Mesoporous silica compositions comprising inflammatory cytokines comprising inflammatory cytokines for modulating immune responses

 #520
20180333413
2018-11-22

Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide

 #521
20180333402
2018-11-22

Pharmaceutical formulations compromising nitrocatechol derivatives and methods of making thereof

 #522
20180325895
2018-11-15

Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide

 #523
20180325822
2018-11-15

Biochars for use with animals

 #524
20180311234
2018-11-01

Device and kit for dosing and dispensing non-liquid medicine

 #525
20180311170
2018-11-01

Pharmaceutical composition containing clomipramine and preparation method therefor

 #526
20180311165
2018-11-01

Sustained-release silica composite depot non-steroidal anti-inflammatory drug delivery

 #527
20180311150
2018-11-01

Hydrogel composite depot formulation

 #528
20180296615
2018-10-18

PHARMACEUTICAL COMPOSITION OR FUNCTIONAL HEALTH FOOD FOR PREVENTING AND TREATING METABOLIC DISEASES, CONTAINING WATER EXTRACT OF PLEUROTUS ERYNGII VAR. FERULAE (PF.) AS ACTIVE INGREDIENT

 #529
20180296479
2018-10-18

Rapidly Dispersible Dosage Form with High Drug Content

 #530
20180280304
2018-10-04

Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product

 #531
20180280303
2018-10-04

Hierarchical siliceous mesosilicalite nanocarrier

 #532
20180265402
2018-09-20

Polyphosphate glass microspheres, methods of making and uses thereof

 #533
20180263896
2018-09-20

Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers

 #534
20180243256
2018-08-30

Solid soluble ferric pyrophosphate formulations, kits, and methods using the same

 #535
20180243210
2018-08-30

METHOD FOR TREATING INTESTINAL FIBROSIS

 #536
20180228889
2018-08-16

Heat stable liquid rotavirus vaccine

 #537
20180228798
2018-08-16

Gastro-resistant formulation containing posaconazole

 #538
20180228779
2018-08-16

Modified release compositions comprising tacrolimus

 #539
20180228731
2018-08-16

Polyphenolic polymer to make water-insoluble molecules become water-soluble

 #540
20180221432
2018-08-09

Drug for the effective control of acute and or chronic pain and a method for its administration

 #541
20180221282
2018-08-09

METHODS FOR MAKING PHARMACEUTICAL SOLID DOSAGE FORMS OF SPRAY-DRIED DISPERSIONS

 #542
20180221280
2018-08-09

Heat-stable dry powder pharmaceutical compositions and methods

 #543
20180214422
2018-08-02

Solid dispersions comprising tacrolimus

 #544
20180185437
2018-07-05

Granular Pharmaceutical Composition

 #545
20180185289
2018-07-05

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

 #546
20180177806
2018-06-28

Dosage form comprising an active ingredient and a plurality of solid porous microcarriers

 #547
20180154050
2018-06-07

Reduction of implant infection via tunable stimulation of localized adaptive immune response

 #548
20180133308
2018-05-17

Vaccine compositions having improved stability and immunogenicity

 #549
20180126349
2018-05-10

Biochar extracts and method for capturing material extracted from biochar

 #550
20180125784
2018-05-10

Delayed release pharmaceutical formulation and methods of making and using same

 #551
20180125776
2018-05-10

COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS

 #552
20180104191
2018-04-19

POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS

 #553
20180092987
2018-04-05

HOLLOW SILICA NANOSPHERES AND METHODS OF MAKING SAME

 #554
20180078544
2018-03-22

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #555
20180078505
2018-03-22

Procedure for preparing enteric-coated pellets containing a proton pump inhibitor and multi-particle pharmaceutical compositions containing them

 #556
20180071395
2018-03-15

Pharmaceutical preparations containing highly volatile silicones

 #557
20180064751
2018-03-08

COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA

 #558
20180055800
2018-03-01

Pulmonary Delivery for Levodopa

 #559
20180055765
2018-03-01

Porous photonic crystals for drug delivery to the eye

 #560
20180043054
2018-02-15

Hemostatic compositions and methods of making thereof

 #561
20180042888
2018-02-15

Monensin water dispersible granules by wet granulation

 #562
20180036253
2018-02-08

Dosator apparatus for filling a capsule with dry powder

 #563
20180036242
2018-02-08

Sustained release particle formulations

 #564
20180030043
2018-02-01

Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate

 #565
20180028646
2018-02-01

Polyelectrolyte multilayers assembled from immune signal compounds

 #566
20180028469
2018-02-01

Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same

 #567
20180015139
2018-01-18

Low-Dose Stable Formulations of Linaclotide

 #568
20180008615
2018-01-11

Nasal pharmaceutical compositions with a porous excipient

 #569
20180000739
2018-01-04

Active ingredient containing stabilised solid forms and method for the production thereof

 #570
20170368085
2017-12-28

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

 #571
20170368048
2017-12-28

Pharmaceutical composition comprising amorphous lenalidomide

 #572
20170360874
2017-12-21

Combination formulation of three antiviral compounds

 #573
20170354601
2017-12-14

ION IMPLANTATION OF MAGNETIC ELEMENTS INTO NANODIAMOND PARTICLES TO FORM COMPOSITION FOR MEDICAL USAGE

 #574
20170348260
2017-12-07

Nasal irrigation

 #575
20170348223
2017-12-07

Controlled release of active substances

 #576
20170340707
2017-11-30

System and Method for Multiphasic Release of Growth Factors

 #577
20170340566
2017-11-30

Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

 #578
20170312346
2017-11-02

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

 #579
20170312258
2017-11-02

TIOTROPIUM DRY POWDERS

 #580
20170312221
2017-11-02

PHARMACEUTICAL PREPARATION AND METHOD OF ITS PRODUCTION AND USE

 #581
20170306221
2017-10-26

ENCAPSULATED MATERIALS IN POROUS PARTICLES

 #582
20170304791
2017-10-26

Biochar extracts and method for capturing material extracted from biochar

 #583
20170304564
2017-10-26

Methods for producing respirable dry powders

 #584
20170281609
2017-10-05

Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same

 #585
20170281549
2017-10-05

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

 #586
20170281544
2017-10-05

Oxygen-enabled composition

 #587
20170266305
2017-09-21

Pharmaceutical composition of polyethylene glycol-modified camptothecin derivative and preparation method thereof

 #588
20170266259
2017-09-21

System and Method for Multiphasic Release of Growth Factors

 #589
20170258906
2017-09-14

Virus-PCION complex having enhanced antitumor effect by using electromagnetic field

 #590
20170258812
2017-09-14

Injectable neurosteroid formulations containing nanoparticles

 #591
20170252302
2017-09-07

Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates

 #592
20170252295
2017-09-07

EFFERVESCENT COMPOSITION AND METHOD OF MAKING IT

 #593
20170246225
2017-08-31

Oral composition containing bifidobacteria and cruciferous vegetable

 #594
20170246112
2017-08-31

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS

 #595
20170239229
2017-08-24

Abuse resistant formula

 #596
20170231907
2017-08-17

Water-soluble granular material for producing a drinking soltuion

 #597
20170225958
2017-08-10

FUNCTIONAL PARTICLES, PRODUCTION PROCESS AND USES

 #598
20170224786
2017-08-10

BOTULINUM TOXIN COMPOSITIONS

 #599
20170216207
2017-08-03

Fine dry particulate adenosine compositions and topical formulations including the same

 #600
20170209504
2017-07-27

Probiotic formulations and methods for use